Stroke incidence was numerically higher with low‐dose rivaroxaban than with standard‐dose rivaroxaban (16.7% versus 5.9%), although this difference did not reach statistical significance (HR, 4.03 [95% CI, 0.25–66.16]; P =0.329; Table S16 ).
← all excerpts
Coronary Embolism in Atrial Fibrillation: A Distinct High-Risk Phenotype With Residual Thromboembolic Risk Despite Anticoagulation.
1
0.3290
0.3290